CCL20 and metabolic dysfunction-associated steatohepatitis: Noteworthily, experimental studies showed that in vivo knockdown of CCL20 reduced LPS-associated hepatic injury, suggesting that CCL20 may play a mediator role in hepatic inflammation, damage, and fibrosis in NAFL and NASH (31).